Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the pruritus therapeutic market grown in recent years?

The size of the pruritus treatment market has substantially expanded in the preceding years. The market is predicted to increase from $14.29 billion in 2024 to $15.43 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 8.0%. This growth can be credited to factors such as an increase in pruritus cases, advancement in R&D, rise in the aging population, expansion of the healthcare infrastructure, improved patient awareness, and strategic collaborations and partnerships.

How is the pruritus therapeutic market size expected to evolve during the forecast period?

Expectations are high for the pruritus therapeutic market, with strong growth forecasted in the upcoming years. The market size is projected to reach $22.02 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%. Several factors contribute to this predicted growth during the forecast period, among them are ongoing research and innovation, the expansion of emerging markets, increased healthcare spending, the trend towards personalized medicine, and regulatory backing for innovative practices. Key trends to watch during this period include telemedicine and the integration of digital health, technological advancements, telehealth, digital health solutions, the evolving global regulatory landscape, biologics, immunomodulators, and approaches that focus on the patient.

Get your pruritus therapeutic market report here!

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

Which key drivers are propelling the pruritus therapeutic market’s growth?

A rise in skin afflictions is substantially fueling the pruritus therapeutic market’s expansion. Dermatological conditions or skin disorders such as acne, eczema, skin cancer, psoriasis, and vitiligo are referred to as skin conditions, impacting the skin. Pruritus therapeutics are often used in the treatment of various skin diseases since pruritus is a key symptom in many disorders. For example, the American Academy of Dermatology Association, a US-based dermatology association, predicted in April 2022 that melanoma would cause the death of 7,650 people that year, including 5,080 males and 2,570 females. Further, in January 2023, according to the American Cancer Society, a US-based volunteer group, it was projected that 97,610 new melanoma cases would be identified in the United States that year, with about 58,120 in men and 39,490 in women. Thus, the escalating rates of skin disorders are propelling the growth of the pruritus therapeutic market.

What are the market segments in the pruritus therapeutic industry?

The pruritus therapeutic market covered in this report is segmented –

1) By Type: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Others Types

2) By Disease Type: Atopic Dermatitis Or Eczema, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types

3) By Application: External Use, Oral, Injection

4) By End Use: Hospitals, Clinics, Other Uses

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines

3) By Local Anesthetics: Topical Local Anesthetics, Injectable Local Anesthetics

4) By Counterirritants: Menthol-Based Products, Camphor-Based Products

5) By Immunosuppressants: Systemic Immunosuppressants, Topical Immunosuppressants

6) By Calcineurin Inhibitors: Tacrolimus, Pimecrolimus

7) By Other Types: Antidepressants, Phototherapy Treatments, Herbal Remedies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9925&type=smp

Which leading companies are shaping the growth of the pruritus therapeutic market?

Major companies operating in the pruritus therapeutic market include Astellas Pharma Inc., Bristol-Myers Squibb Company, Cipla Inc., Eli Lilly and Company, Galderma Laboratories LP, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Abbott Laboratories, Almirall SA, Eisai Co. Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Chemicals Ltd., Cara Therapeutics Inc., EPI Health LLC, AbbVie Inc., Albireo Pharma Inc., Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Huapont Life Sciences Co. Ltd., LEO Pharma AS, MC2 Therapeutics Ltd., Novan Inc., Trevi Therapeutics Inc., UCB SA, Viatris Inc., Teva Pharmaceutical Industries Ltd.

What key trends are currently impacting the pruritus therapeutic market’s development?

The primary trend gaining traction in the pruritus therapeutic market is product innovation. Major players in this market are putting their focus on the creation of novel treatments and medications for pruritus and similar conditions. For instance, Maruho Co., Ltd., a pharmaceutical company based in Japan, made a noteworthy stride in August 2022 by launching the anti-IL-31 receptor, a Mitchga Subcutaneous Injection with 60 mg Syringes. This humanized monoclonal antibody serves to treat itching that often stems from atopic dermatitis. It’s the first of its kind to inhibit IL-31 signaling, a cytokine connected to pruritus and skin inflammation during the progression of atopic dermatitis. The drug works by preventing IL-31 from binding to its receptor, in the process helping to curb itch and inflammation that occur as a result of atopic dermatitis.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9925

Which geographic areas are influencing the growth of the pruritus therapeutic market?

North America was the largest region in the pruritus therapeutic market in 2024. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Healthcare Cloud Computing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/healthcare-cloud-computing-global-market-report

Healthcare Reimbursement Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report

Virtual Reality In Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/virtual-reality-in-healthcare-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: